person

Alexandre M. M.

Country
Spain
Department
Medical Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
69
Sites with multiple studies

Has run more than one trial at 69 of 243 partner sites.

Specializations

Lung Cancer Specialization

This investigator focuses on treating non-small cell lung cancer (NSCLC), with particular expertise in various stages and presentations of the disease, including Pancoast tumors and resectable Stage II-IIIB cases.

  • Advanced surgical oncology
  • Early-stage lung cancer management
  • Complex tumor resection

Their practice encompasses both early-stage and locally advanced disease states requiring surgical intervention.

Targeted Therapy Expertise

The investigator specializes in EGFR mutation-positive NSCLC treatment, with particular focus on targeted therapies such as osimertinib in various treatment settings.

  • Mutation-specific treatments
  • Neoadjuvant therapy approaches
  • Post-surgical targeted treatments

Their work includes both pre-operative and post-operative therapeutic applications.

Immunotherapy Integration

The investigator has developed expertise in combining immunotherapy with conventional chemotherapy in the treatment of resectable lung cancer, particularly exploring neoadjuvant and adjuvant approaches.

  • Combined modality treatments
  • Perioperative immunotherapy
  • Long-term survival strategies

Their work explores innovative treatment sequences involving surgery and systemic therapies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.